{"product_id":"medicinteknik-leveransavbrott-mdr-ivdr-artikel-10a","title":"Medical Devices – interruption of supply under MDR\/IVDR Article 10a | Word\/PDF\/Excel","description":"\u003cp\u003e\u003cstrong\u003eDo you need to manage a planned supply disruption or the discontinuation of a medical device or IVD product?\u003c\/strong\u003e This document package helps Swedish manufacturers, importers, and distributors collect risk assessment data, decide whether to notify, pass on the manufacturer's information, and retain records. \u003cstrong\u003eImportant:\u003c\/strong\u003e Article 10a is not triggered by every supply delay. Assess whether the disruption could lead to serious harm or a risk of serious harm to patients or public health. The package does not replace the authority's official forms or medical\/regulatory expertise.\u003c\/p\u003e\n\u003ch2\u003eQuick facts and who the template is for\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDocument type:\u003c\/strong\u003e operational compliance and evidence package. \u003cstrong\u003eLegal basis:\u003c\/strong\u003e MDR\/IVDR Article 10a (EU), Swedish authority process where the competent authority is the Swedish Medical Products Agency. \u003cstrong\u003eFiles:\u003c\/strong\u003e 7 editable Word (.docx), 7 searchable printable PDFs, and 1 Excel (.xlsx) with nine tabs – 15 files in total. \u003cstrong\u003eLanguage:\u003c\/strong\u003e five Swedish working templates, a Swedish guide, and an English User Guide; the Excel file is in Swedish. The English guide does not translate the working templates. \u003cstrong\u003ePDF:\u003c\/strong\u003e not interactive fillable forms. \u003cstrong\u003eDelivery:\u003c\/strong\u003e digital ZIP.\u003c\/p\u003e\n\u003csection aria-label=\"Package contents\" style=\"border:1px solid #91adc4;border-radius:10px;padding:18px 20px;margin:22px 0;background:#eef5fb\"\u003e\u003ch2 style=\"margin:0 0 10px\"\u003e01 – Package contents\u003c\/h2\u003e\n\n\u003cp\u003eFive Swedish working documents (risk assessment, notification decision, manufacturer data, onward transmission, and recipient log), a Swedish user guide, and a separate English user guide. All seven are available as both DOCX and searchable PDF. In addition, there is a Swedish Excel register. \u003cstrong\u003eSeven standalone documents, 15 customer files\u003c\/strong\u003e.\u003c\/p\u003e\u003c\/section\u003e\n\u003csection aria-label=\"What the files contain\" style=\"border:1px solid #91adc4;border-radius:10px;padding:18px 20px;margin:22px 0;background:#fff\"\u003e\u003ch2 style=\"margin:0 0 10px\"\u003e02 – What the files contain\u003c\/h2\u003e\n\n\u003cp\u003eRole and product scoping, medical risk questionnaire, reasoned notification decision, checklist for official authority notification, faithful transmission to downstream recipients, transmission and proof of receipt records, and an action log. The Excel file compiles administrative cases and open actions without automatically determining legal compliance.\u003c\/p\u003e\u003c\/section\u003e\n\u003ch2\u003eWho should choose the package – and when is it not suitable?\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eSituation 1:\u003c\/strong\u003e A manufacturer anticipates that the availability of an affected product will cease and needs to document patient risk, affected Member States, and recipients before notifying the authority. \u003cstrong\u003eSituation 2:\u003c\/strong\u003e An importer\/distributor has received the manufacturer's Article 10a notice and needs to pass on the original information without unnecessary delay and save proof of transmission.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eChoose other documentation\u003c\/strong\u003e for routine supply planning only without relevant serious risk, for a clinical assessment of a replacement product, or for MDR\/IVDR registration in EUDAMED. Specially adapted products are not covered by Article 10a under the specified EU regulation; the classification must be checked. Old so-called legacy products may be covered.\u003c\/p\u003e\n\u003ch2\u003eExact file list\u003c\/h2\u003e\n\u003cdiv style=\"overflow-x:auto\"\u003e\u003ctable style=\"border-collapse:collapse;width:100%\"\u003e\n\n\u003cthead\u003e\u003ctr\u003e\n\n\u003cth scope=\"col\"\u003eDocument\u003c\/th\u003e\n\n\u003cth scope=\"col\"\u003eUse\u003c\/th\u003e\n\n\u003cth scope=\"col\"\u003eLanguage\u003c\/th\u003e\n\n\u003cth scope=\"col\"\u003eFormat\u003c\/th\u003e\n\n\n\u003c\/tr\u003e\u003c\/thead\u003e\n\n\u003ctbody\u003e\n\n\u003ctr\u003e\n\n\u003ctd\u003e01 Applicability and risk assessment\u003c\/td\u003e\n\n\u003ctd\u003eIdentify product\/actor, assess relevant serious patient\/public health risk, and document uncertainty\u003c\/td\u003e\n\n\u003ctd\u003eSV\u003c\/td\u003e\n\n\u003ctd\u003eDOCX + PDF\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\n\u003ctr\u003e\n\n\u003ctd\u003e02 Action and notification decision\u003c\/td\u003e\n\n\u003ctd\u003eReasoned decision, recipients, planned actions, and actual date\u003c\/td\u003e\n\n\u003ctd\u003eSV\u003c\/td\u003e\n\n\u003ctd\u003eDOCX + PDF\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\n\u003ctr\u003e\n\n\u003ctd\u003e03 Manufacturer's notification data\u003c\/td\u003e\n\n\u003ctd\u003ePrepare facts for the official MDCG form and authority process\u003c\/td\u003e\n\n\u003ctd\u003eSV\u003c\/td\u003e\n\n\u003ctd\u003eDOCX + PDF\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\n\u003ctr\u003e\n\n\u003ctd\u003e04 Faithful onward transmission\u003c\/td\u003e\n\n\u003ctd\u003eCover letter, unaltered manufacturer original, and distribution tracking\u003c\/td\u003e\n\n\u003ctd\u003eSV\u003c\/td\u003e\n\n\u003ctd\u003eDOCX + PDF\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\n\u003ctr\u003e\n\n\u003ctd\u003e05 Recipient and action log\u003c\/td\u003e\n\n\u003ctd\u003eProof of transmission, receipts, follow-up, and closure check\u003c\/td\u003e\n\n\u003ctd\u003eSV\u003c\/td\u003e\n\n\u003ctd\u003eDOCX + PDF\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\n\u003ctr\u003e\n\n\u003ctd\u003e06 User guide\u003c\/td\u003e\n\n\u003ctd\u003ePreparations, workflow, exceptions, and checklist\u003c\/td\u003e\n\n\u003ctd\u003eSV\u003c\/td\u003e\n\n\u003ctd\u003eDOCX + PDF\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\n\u003ctr\u003e\n\n\u003ctd\u003e07 English User Guide\u003c\/td\u003e\n\n\u003ctd\u003eEnglish instructions for using the Swedish working documents\u003c\/td\u003e\n\n\u003ctd\u003eEN\u003c\/td\u003e\n\n\u003ctd\u003eDOCX + PDF\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\n\u003ctr\u003e\n\n\u003ctd\u003e08 Evidence register\u003c\/td\u003e\n\n\u003ctd\u003eCases, risk assessments, products, recipients, notifications, onward transmission, and actions\u003c\/td\u003e\n\n\u003ctd\u003eSV\u003c\/td\u003e\n\n\u003ctd\u003eXLSX\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\n\n\u003c\/tbody\u003e\n\n\n\u003c\/table\u003e\u003c\/div\u003e\n\u003cp\u003eThe Word files are editable; the PDF files can be read, searched, and printed but lack interactive form fields. Excel requires spreadsheet software that supports XLSX formulas and data validation, preferably Microsoft Excel. No macros are included.\u003c\/p\u003e\n\u003ch2\u003eThe Excel tool in practice\u003c\/h2\u003e\n\u003cp\u003eThe workbook has nine tabs: \u003cstrong\u003eStart, Cases, Risk assessment, Products, Recipients, Notifications, Onward transmission, Actions, Read me, and Sources\u003c\/strong\u003e. The start page uses controlled COUNTA\/COUNTIF formulas for the number of registered\/ongoing cases, unassessed risks, sent notifications, unacknowledged recipients, and open actions. For example: if a recipient has the status “Unacknowledged,” it is displayed in the summary, but this does not mean that the message was actually missed or that a legal requirement is automatically met.\u003c\/p\u003e\n\u003ch2\u003eWorkflow from forecast to evidence\u003c\/h2\u003e\n\u003col\u003e\n\n\u003cli\u003eIdentify product, manufacturer, MDR\/IVDR status, and forecasted disruption.\u003c\/li\u003e\n\n\u003cli\u003eLet the relevant medical\/regulatory function assess the threshold for serious harm or risk.\u003c\/li\u003e\n\n\u003cli\u003eDocument reasoning, recipient group, date, any exceptions, and realistic actions.\u003c\/li\u003e\n\n\u003cli\u003eIf manufacturer obligation applies: check the current official MDCG 2024-16 Manufacturer Information Form and the correct competent authority; do not send only this Word template.\u003c\/li\u003e\n\n\u003cli\u003eAs importer\/distributor: pass on the manufacturer's original unaltered without unnecessary delay to relevant direct customers.\u003c\/li\u003e\n\n\u003cli\u003eDocument actual proof of transmission\/receipt and follow up on consequences and changes.\u003c\/li\u003e\n\n\n\u003c\/ol\u003e\n\u003ch2\u003eLegal requirements\u003c\/h2\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/eur-lex.europa.eu\/eli\/reg\/2024\/1860\/oj?locale=sv\"\u003eRegulation (EU) 2024\/1860\u003c\/a\u003e introduced Article 10a in both the MDR and IVDR. The requirement has been applicable since \u003cstrong\u003eJanuary 10, 2025\u003c\/strong\u003e. When the manufacturer's planned disruption or discontinuation can reasonably be expected to lead to serious harm or a risk of serious harm, the manufacturer must normally inform the competent authority and specified direct recipients \u003cstrong\u003eat least six months in advance\u003c\/strong\u003e, except in exceptional circumstances. Article 10a.3 further requires onward transmission downstream without unnecessary delay. The correct recipient authority depends on the manufacturer's or authorized representative's country of establishment; the Swedish Medical Products Agency is not always the competent authority.\u003c\/p\u003e\n\u003cp\u003eSee the \u003ca href=\"https:\/\/www.lakemedelsverket.se\/sv\/medicinteknik\/folj-upp-anvandning\/rapportera-avbrott-i-leverans\"\u003eSwedish Medical Products Agency's instructions\u003c\/a\u003e and the \u003ca href=\"https:\/\/health.ec.europa.eu\/medical-devices-sector\/new-regulations\/guidance-mdcg-endorsed-documents-and-other-guidance_en\"\u003eEuropean Commission's MDCG guidance and forms\u003c\/a\u003e. An authority form must be checked separately; it is not included as a replacement in the package. Individual clinical assessment and any other product liability\/recall actions require separate expertise.\u003c\/p\u003e\n\u003ch2\u003eCompare with related documents\u003c\/h2\u003e\n\u003cp\u003e\u003ca href=\"\/en\/products\/eudamed-2026-legacy-udi-registrering-28-november\"\u003eEUDAMED – registration and UDI\u003c\/a\u003e helps with other regulatory administration. A general supplier or risk management agreement does not replace a role-specific Article 10a notification. The product's Excel register is not an inventory planning system or clinical decision support tool.\u003c\/p\u003e\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\u003ch3\u003eMust all supply delays be reported?\u003c\/h3\u003e\u003cp\u003eNo. Article 10a presupposes the described risk of serious harm or risk of serious harm; assess and document the circumstances.\u003c\/p\u003e\n\u003ch3\u003eDo manufacturers and distributors have the same obligation?\u003c\/h3\u003e\u003cp\u003eNo. The manufacturer primarily assesses reporting and information under Article 10a.1. Downstream economic operators pass on the received manufacturer information under Article 10a.3.\u003c\/p\u003e\n\u003ch3\u003eIs it enough to send the Word template to the Swedish Medical Products Agency?\u003c\/h3\u003e\u003cp\u003eNo. The manufacturer's Word template is an internal preparation document. Check and use the current official form and relevant submission instructions.\u003c\/p\u003e\n\u003ch3\u003eCan Excel determine if the six-month deadline has been met?\u003c\/h3\u003e\u003cp\u003eNo. Excel reports actual registrations and status, not a legal deadline assessment or authority confirmation.\u003c\/p\u003e\n\u003ch3\u003eAre the PDF files fillable or the templates in English?\u003c\/h3\u003e\u003cp\u003eThe PDF files are searchable and printable but not interactively fillable. The main templates are in Swedish; only the user guide is available separately in English.\u003c\/p\u003e\n\u003ch2\u003eVersion, sources, and transparency\u003c\/h2\u003e\n\u003cp\u003eEdition \u003cstrong\u003e1.0, November 14, 2026\u003c\/strong\u003e. AI-assisted legal source review and internal file check have been performed as of this date; \u003cstrong\u003eno independent lawyer, legal, medical expert, or authority review\u003c\/strong\u003e is claimed. Forms, authority instructions, affected products, and risk assessment must be checked at the time of actual use. Trademark: Mallbutiken.se; supplier: Svenska Dokumentmallar.\u003c\/p\u003e","brand":"Svenska Dokumentmallar","offers":[{"title":"Default Title","offer_id":56620543836502,"sku":"MB-MDR10A-LEV-20261114-V1","price":79.0,"currency_code":"SEK","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0827\/2373\/3846\/files\/01-mdr-ivdr-artikel10a-huvudbild-1600.png?v=1794653212","url":"https:\/\/mallbutiken.se\/en\/products\/medicinteknik-leveransavbrott-mdr-ivdr-artikel-10a","provider":"Mallbutiken","version":"1.0","type":"link"}